Analyst Expects Doximity Inc (NYSE: DOCS) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NYSE listed company, DOCS falls under the Healthcare sector while operating within the Health Information Services industry segment. The current market capitalization of Doximity Inc is $12.93B. A total of 1.19 million shares were traded on the day, compared to an average of 1.67M shares.

In the most recent transaction, Cabral Timothy S sold 6,360 shares of DOCS for 66.30 per share on Sep 02 ’25. After the transaction, the Director now owns 3,221 company shares. In a previous transaction on Sep 02 ’25, Wampler Kira Scherer sold 2,000 shares at 66.57 per share. DOCS shares that Director owns now total 19,839.

Among the insiders who bought shares, TIMOTHY CABRAL acquired of 6,360 shares on Sep 02 ’25 at a per-share price of $66.30. In another insider transaction, KIRA WAMPLER bought 2,000 shares at $66.57 per share on Sep 02 ’25.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DOCS has a high of $85.21 and a low of $36.12.

As of this writing, DOCS has an earnings estimate of $0.38 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of $0.41 per share and a lower estimate of $0.33. The company reported an EPS of $0.3 in the last quarter

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DOCS’s latest balance sheet shows that the firm has $798.11M in Cash & Short Term Investments as of fiscal 2022. There were $1.09M in debt and $111.28M in liabilities at the time. Its Book Value Per Share was $5.47, while its Total Shareholder’s Equity was $878.59M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DOCS is Buy with a score of 3.90.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.